SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know

By sjmartinez • January 3, 2024

Greene SJ, Fonarow GC, Butler J. SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know. Am J Cardiovasc Drugs. 2023 Dec 29. doi: 10.1007/s40256-023-00624-2. Epub ahead of print. PMID: 38157160.

Tags: Cardiology/Epi, Publications

3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant[...]

The Association of Arsenic Exposure and Metabolism Biomarkers with Subclinical Measures of Liver Disease: a cross-sectional investigation in the Multi-Ethnic Study of Atherosclerosis

Wu HC, Glabonjat RA, Schilling K, Anderson WA, Gao S, Relloso AD, LoIacono N, Slowly M, Nigra AE, Sanchez T, Sobel MH, Galvez-Fernandez M, Budoff[...]

Clinical and socioeconomic factors associated with recurrent atrial fibrillation after catheter ablation or antiarrhythmic drug therapy

An J, Bansal N, Zheng C, Lee MS, Wei R, Harrison TN, Fan D, Garcia E, Lidgard B, Zelnick LR, Singer DE, Go AS. Clinical[...]